BUY
Good price. TD Waterhouse and loan loss provisions have hurt. Could drop further, but good long term.
BUY
Demographics for pharmaceuticals is good. Could be volatile during their election period. Good long term.
DON'T BUY
Has a lot of problems. There could be more bad news.
DON'T BUY
Still vulnerable. Guidance is too high. Will take time.
BUY
Well run. Cyclical. Weakening of economy has made it vulnerable. Likes their Methanex holdings. Buy for long term.
WEAK BUY
Has done well. 30% of sales are in Europe which could make them vulnerable. Not a cheap stock.
BUY
Lagged because of their hedging strategy, but now cleaning these up. Sells at a discount to other golds, so could move up.
DON'T BUY
If it survives, could go to $3/5 in 5/10 years. Large debt. Very speculatice.
WAIT
A good trust. Kyoto accord has created a weakness.
BUY
Positive on oil stocks because of mid east problems. Good price.
DON'T BUY
BUY
Their subsiduary, The Investors Group, has weakened the stock. Should do well. Good management.
DON'T BUY
Taking some market share from other airlines. Should do well if economy improves. Volatile.
BUY
Balance sheet is in good shape to make acquisitions. Earnings only grow 5/6%, but dividend of 4.5% gives you an 8/9% return.
DON'T BUY
The most market sensitive bank because of exposure to investment banking. Prefers other banks.